FDA Requires Black Box Warning for Invokana® Due to Risk of Foot or Leg Amputations

Tipped over bottle of pills.

The Food and Drug Administration (FDA) has just issued a warning that JOHNSON & JOHNSON’S diabetes drug Invokana® presents a significant risk of causing foot or leg amputations.

The FDA’s warning comes after two clinical trials showing foot and leg amputations occurred about twice as often in patients taking the diabetes drug Invokana®.

The FDA is now requiring that Invokana® contain a “boxed warning” which is the type of warning that is reserved for the most serious possible adverse consequences associated with a pharmaceutical product.

The lawyers at Strauss Troy have substantial experience representing people who have been injured as a result of dangerous pharmaceutical products and medical devices. If you have been taking Invokana® and have had an amputation, or are in danger of amputation in the near future, we would like to talk to you. There is no charge for the initial consultation.

For more information, contact:
Ronald R. Parry
Strauss Troy